The basics: Small cell lung cancer (SCLC) and
If you've already been through treatment for small cell lung cancer,
then you probably know a good bit about it already. Here are some
reminders and maybe some new terms that can help you
understand treatment with ZEPZELCA® (lurbinectedin).
What is small cell lung cancer (SCLC)?
Cancer starts when abnormal cells in the body grow out of control. Lung cancer starts in the lungs.
There are 2 types of lung cancer. One is called non–small cell lung cancer. The other is called small cell lung cancer, or SCLC.
SCLC tends to grow and spread quickly. That’s why it tends to respond to chemotherapy and radiation therapy. For the same reason, SCLC comes back for most people.
What is metastatic
Cancer that has spread from the lungs, where it started, to other parts of the body.
What is progression?
Disease that has spread and grown.
Treatment for small cell lung cancer (SCLC)
- Cisplatin + etoposide or irinotecan
- Carboplatin + etoposide or irinotecan
SCLC often responds to first-line chemotherapy.
But it usually comes back sooner or later.
When SCLC comes back
There are still treatment options when the first
treatment did not work or is no longer working.
- With SCLC that has spread and
- Who have already tried cisplatin or carboplatin
Tip: Many people find that connecting with others who are going through
similar experiences can be helpful.
Learn about support groups and more >>
It can be hard to hear that SCLC has come back.
But ZEPZELCA can help you keep fighting.
Get answers to Frequently asked questions about small cell lung cancer >>